View More Recent Stories

Oct 9, 2024 09:07AM Travere Therapeutics (TVTX) PT Raised to $13 at Stifel
Sep 30, 2024 06:59AM Travere Therapeutics (TVTX) PT Lowered to $22 at Canaccord Genuity
Sep 30, 2024 06:13AM Travere Therapeutics (TVTX) PT Raised to $18 at Barclays
Sep 27, 2024 07:39AM TD Cowen Reiterates Buy Rating on Travere Therapeutics (TVTX)
Sep 27, 2024 07:23AM Travere Therapeutics (TVTX) PT Lowered to $19 at Citi
Sep 27, 2024 06:43AM Travere Therapeutics (TVTX) PT Lowered to $18 at H.C. Wainwright
Sep 27, 2024 05:59AM Travere Therapeutics (TVTX) PT Lowered to $18 at BofA Securities
Sep 26, 2024 04:49PM After-hours movers: Costco, Scholastic Corp, Travere Therapeutics
Sep 26, 2024 04:01PM Travere Therapeutics (TVTX) Announces Voluntary Pause of Enrollment in the Phase 3 HARMONY Study of Pegtibatinase
Sep 10, 2024 07:23AM Travere Therapeutics (TVTX) PT Raised to $23 at Canaccord Genuity
Sep 6, 2024 09:49AM Travere Therapeutics (TVTX) PT Raised to $23 at Citi, 'Full Approval as Expected and We Expect Positive Inflection in Sales Trajectory'
Sep 6, 2024 06:12AM Travere Therapeutics (TVTX) PT Raised to $23 at H.C. Wainwright
Sep 6, 2024 05:42AM Travere Therapeutics (TVTX) PT Raised to $19 at BofA Securities
Sep 5, 2024 04:54PM Travere Therapeutics (TVTX) Halted, News Pending
Aug 28, 2024 09:00AM Piper Sandler Reiterates Neutral Rating on Travere Therapeutics (TVTX)
Aug 2, 2024 07:30AM Travere Therapeutics (TVTX) PT Raised to $12 at Piper Sandler
Aug 1, 2024 05:37PM Travere Therapeutics (TVTX) Tops Q2 EPS by 14c
View More Recent Stories